 Connection
Atsushi Oba to Aged, 80 and over
This is a "connection" page, showing publications Atsushi Oba has written about Aged, 80 and over.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.641 |
|
|
|
-
Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, Löhr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
Score: 0.091
-
Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg. 2021 08 19; 108(8):976-982.
Score: 0.071
-
Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, Ito H, Takahashi Y, Saiura A. Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Langenbecks Arch Surg. 2020 Feb; 405(1):35-41.
Score: 0.063
-
Oba A, Mise Y, Ito H, Hiratsuka M, Inoue Y, Ishizawa T, Arita J, Matsueda K, Takahashi Y, Saiura A. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography. HPB (Oxford). 2018 08; 20(8):708-714.
Score: 0.056
-
Oba A, Kudo A, Akahoshi K, Kishino M, Akashi T, Katsuta E, Iwao Y, Ono H, Mitsunori Y, Ban D, Tanaka S, Eishi Y, Tateishi U, Tanabe M. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors. J Gastroenterol. 2017 10; 52(10):1140-1146.
Score: 0.053
-
Oba A, Ban D, Kirimura S, Akahoshi K, Mitsunori Y, Matsumura S, Ochiai T, Kudo A, Tanaka S, Minoru T. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2016 Aug; 23(8):480-8.
Score: 0.050
-
Baba H, Inoue Y, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Robotic Liver Resection With Scope Transition Technique: A Single-Center Experience. Asian J Endosc Surg. 2026 Jan-Dec; 19(1):e70230.
Score: 0.024
-
Shibata Y, Jansson H, Kobayashi K, Yu W, Oba A, Ghorbani P, Ono Y, D'Souza MA, Sturesson C, Ito H, Sparrelid E, Inoue Y, Gilg S, Takahashi Y. Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience. Eur J Surg Oncol. 2026 Jan; 52(1):111159.
Score: 0.024
-
Maekawa A, Oba A, Mie T, Sawa Y, Baba H, Kobayashi K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Sasahira N, Takamatsu M, Ban D, Inoue Y, Takahashi Y. Exploring the role of CA 19-9 dynamics in pancreatic cancer multidisciplinary treatment: Proposal of the PANC classification. Surgery. 2025 Dec; 188:109783.
Score: 0.024
-
Shibata Y, Oba A, Shimane G, Miyata T, Tauchi J, Baba H, Maekawa A, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y. Prognostic role of peritoneal lavage cytology: Proposal for staging laparoscopy criteria in biliary tract cancer. Eur J Surg Oncol. 2025 10; 51(10):110369.
Score: 0.024
-
Maekawa A, Omiya K, Oba A, Inoue Y, Hirose Y, Kobayashi K, Ono Y, Sato T, Sasaki T, Ozaka M, Matsueda K, Mise Y, Takamatsu M, Shigematsu Y, Ito H, Saiura A, Sasahira N, Takahashi Y. Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. Eur J Surg Oncol. 2025 05; 51(5):109635.
Score: 0.023
-
Irie S, Inoue Y, Oba A, Ono Y, Sato T, Mise Y, Ito H, Saiura A, Takahashi Y. Technical Guidelines for Safe Mesojejunum Dissection During Pancreaticoduodenectomy: Unveiling Critical Techniques in a Complex Procedure. Ann Surg Oncol. 2025 Mar; 32(3):1850-1857.
Score: 0.022
-
Kobayashi K, Inoue Y, Oba A, Ono Y, Osumi H, Sato T, Ito H, Mise Y, Shinozaki E, Yamaguchi K, Saiura A, Takahashi Y. Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary Treatment. Ann Surg Oncol. 2025 Mar; 32(3):1729-1741.
Score: 0.022
-
Hirose Y, Oba A, Takamatsu M, Hamada T, Takeda T, Suzuki T, Maekawa A, Kitano Y, Sato S, Kobayashi K, Omiya K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Takeuchi K, Sasahira N, Inoue Y, Wakai T, Takahashi Y. Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. Pancreatology. 2024 Nov; 24(7):1021-1030.
Score: 0.022
-
Kitano Y, Inoue Y, Kobayashi H, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Development of the multiple scope transition method in robotic pancreaticoduodenectomy. Surg Endosc. 2024 10; 38(10):6169-6176.
Score: 0.022
-
Takahashi Y, Sasahira N, Sasaki T, Inoue Y, Mise Y, Sato T, Ono Y, Oba A, Saiura A, Ito H. The role of stent placement above the papilla (inside-stent) as a bridging therapy for perihilar biliary malignancy: an initial experience. Surg Today. 2021 Nov; 51(11):1795-1804.
Score: 0.017
-
Ushida Y, Inoue Y, Ito H, Oba A, Mise Y, Ono Y, Sato T, Saiura A, Takahashi Y. High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. Pancreatology. 2021 Jan; 21(1):130-137.
Score: 0.017
-
Inoue Y, Saiura A, Oba A, Kawakatsu S, Ono Y, Sato T, Mise Y, Ishizawa T, Takahashi Y, Ito H. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. J Gastrointest Surg. 2019 07; 23(7):1373-1383.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|